bioRxiv
Gene editor achieved more editing at lower doses in primate liver
The animal experiment targeted two sites in nonhuman primate liver, with comparisons drawn from preclinical data on Cas9-based therapies.The animal experiment targeted two sites in nonhuman primate liver, with comparisons drawn from preclinical data on Cas9-based therapies.
Preprint: animal studyInterventions
Who was studiedNonhuman primates, against Cas9-based therapies in preclinical studies
What changedEditing in primate liver was higher at lower doses with X-Editor than with Cas9-based therapies in separate preclinical data
The catchThe comparison used separate preclinical Cas9 data rather than a head-to-head experiment